Loading the lesson
Loading the lesson
Search AllRounder.ai
Search the courses, subjects, tracks, games and features, or jump straight to a page.
Search the courses, subjects, tracks, games and features, or jump straight to a page.
Learn it your way
A short class with Sarah and her students. The other ways are under More.
Sign up free to listen. Transcripts are free to read.
Today, we're kicking off with target identification. This is the starting point of drug discovery. Can anyone tell me what a biological target might be?
Isn't it a protein or something that affects a disease?
Exactly! It's often a protein or nucleic acid whose activity impacts a disease. Now, why do we need to validate these targets?
So we know that changing their activity will help treat the disease, right?
Right again! Validation provides experimental proof that targeting it can create a therapeutic effect. Let's remember 'IV' for 'Identify and Validate' — this can help us recall the first step. Any questions?
Now, moving onto lead discovery. Once we have our validated target, we need to find a lead compound. What methods can we use?
Natural products and combinatorial chemistry?
Yes! Natural products are often a great source. Could anyone give an example of a drug derived from them?
Penicillin from fungi?
That’s right! Natural products form a significant basis for many drug discoveries. Now, remember 'CLASH' to help remember these strategies: Combinatorial chemistry, Lead optimization, Automated screening, Structure-based design, and Historical remedies. Any further questions?
Next up is lead optimization. Why do we need to optimize a lead compound?
To improve its effectiveness and reduce side effects?
Exactly! We need to enhance properties such as solubility and selectivity. What’s one method we use to assess the relationship between a compound’s structure and its activity?
Structure-Activity Relationship studies!
Good job! And remember, optimizing drugs is like tuning a musical instrument—it’s all about achieving the perfect balance. How about we summarize this? Optimization includes enhancing bioavailability, reducing toxicity, and improving selectivity. Let’s use the acronym 'POTSON' — Potency, Optimization, Toxicity, Selectivity, and Nurture. Questions?
Now let’s dive into clinical trials. What comes after the pre-clinical tests?
Human clinical trials?
Correct! Clinical trials have three phases. Can anyone briefly outline the main focus of each phase?
Phase I is about safety and dosage, Phase II tests efficacy and side effects, and Phase III confirms efficacy on a larger scale?
I’m impressed! Remembering 'SEC' can help: Safety, Efficacy, Confirmation. This captures the primary goals of the phases. Any clarifying questions?
Finally, let's talk about regulatory approval and post-market surveillance. What happens when a drug passes Phase III trials?
The drug gets evaluated by regulatory agencies?
Exactly! Agencies like the FDA review all trial data to decide on marketing approval. If approved, what's next?
Post-market surveillance to watch for long-term effects?
Yes! This ensures any rare side effects are caught once the drug is available to everyone. Let's remember 'RAPID' for Regulatory Approval Process Including Data. Any last questions?
Identifying biological targets linked to diseases.
Finding lead compounds that interact with the identified targets.
Refining lead compounds to improve their pharmacological properties.
Conducting laboratory and animal tests to evaluate drug safety and efficacy.
Phased testing of drugs on humans to assess safety and effectiveness.
Process by which drugs are approved for market after thorough evaluation.
Monitoring drug effects and side effects after market release.
Identification, Validation, leads the creation, Drug discovery starts with strong foundation.
Imagine a scientist embarking on a journey to find a medical treasure. First, they need to discover a key (the biological target) hidden in the body. They must then validate its role in a disease, often needing allies (research data) to prove its significance before the quest for the essential lead (compound) begins.
Remember 'SEC' for the phases of clinical trials: Safety, Efficacy, Confirmation.
Use 'IVR' to remember the first parts of drug discovery: Identify, Validate, Research for targets.
Term
First step in drug discovery
Click to flip
Term
Process after phase III trials
Click to flip
Term
Iterative process to improve lead compounds
Click to flip
Term
Tests on animals before humans
Click to flip
The process of discovering biological targets, typically proteins or nucleic acids, involved in diseases.
The stage of drug development where potential drug candidates are identified.
The iterative process of refining and improving the properties of lead compounds.
The testing phase in laboratories and animal models prior to human trials.
Structured phases of testing conducted on humans to assess a drug's safety and efficacy.
The formal process through which regulatory bodies approve drugs for market use.
Monitoring the safety and efficacy of drugs after they have been made available to the public.
This section covers the comprehensive and complex process of drug discovery and development, from target identification to regulatory approval.
The drug discovery and development process is a lengthy, costly venture that spans over a decade. It involves several crucial stages including target identification and validation, lead discovery, lead optimization, pre-clinical trials, clinical trials, and regulatory approval, each presenting unique challenges and intricacies.
The creation of new pharmaceuticals begins with the intricate field of medicinal chemistry, where chemistry meets biology and pharmacology to facilitate drug design and development. The entire process is lengthy, demanding, and financially exhaustive, often extending over a decade and requiring billions of dollars.
Target Identification and Validation: The initial step involves identifying a biological target, typically a protein or nucleic acid linked to a disease. Validation confirms that altering this target's activity will lead to a desired therapeutic effect.
Lead Discovery: Following validation, researchers seek a lead compound exhibiting preliminary activity. Diverse strategies include:
Lead Optimization: The discovered lead might require modifications to improve properties like solubility, stability, and selectivity without sacrificing therapeutic efficacy. This involves:
Pre-clinical Trials: Rigorous testing in laboratory and animal models assesses pharmacology and toxicology, including safety evaluations.
Clinical Trials: After successful pre-clinical results, the drug undergoes human trials in three distinct phases:
Regulatory Approval and Post-market Surveillance: Post phase III, regulatory bodies review data to grant approval for public use, followed by ongoing monitoring for long-term effects and rare side effects post-marketing.
Understanding this entire journey from conceptualization to clinical application reflects the intricacies and collaborative efforts in medicinal chemistry aimed at enhancing therapeutic solutions.